NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,368,122 | -7.0% | 30,918 | +2.3% | 0.01% | 0.0% |
| Q2 2023 | $1,470,943 | -11.7% | 30,229 | +0.7% | 0.01% | -20.0% |
| Q1 2023 | $1,666,322 | +42.8% | 30,013 | +3.3% | 0.02% | +36.4% |
| Q4 2022 | $1,167,139 | +7.1% | 29,055 | +16.9% | 0.01% | 0.0% |
| Q3 2022 | $1,090,000 | +25.1% | 24,864 | +1.2% | 0.01% | +37.5% |
| Q2 2022 | $871,000 | -6.9% | 24,579 | +6.8% | 0.01% | 0.0% |
| Q1 2022 | $936,000 | -55.9% | 23,013 | +1.3% | 0.01% | -50.0% |
| Q4 2021 | $2,122,000 | -11.7% | 22,717 | +5.4% | 0.02% | -20.0% |
| Q3 2021 | $2,403,000 | +0.3% | 21,560 | +2.2% | 0.02% | +5.3% |
| Q2 2021 | $2,395,000 | +11.7% | 21,094 | -0.1% | 0.02% | 0.0% |
| Q1 2021 | $2,145,000 | +9.4% | 21,124 | +7.3% | 0.02% | +5.6% |
| Q4 2020 | $1,960,000 | +34.3% | 19,693 | -2.5% | 0.02% | +20.0% |
| Q3 2020 | $1,459,000 | +95.6% | 20,190 | +34.9% | 0.02% | +36.4% |
| Q2 2020 | $746,000 | +96.3% | 14,965 | +17.5% | 0.01% | +57.1% |
| Q1 2020 | $380,000 | – | 12,741 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |